GP5 and cervical squamous intraepithelial neoplasia: The evidence from the randomized controlled trials (using HC2 or GP5+/6+ PCR assays) showed that HPV testing offers better protection from cervical cancer to screened women than cytology [1], but at the cost of substantially more false-positive tests and low-grade CIN diagnoses even in women aged ≥30 years [13].